Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 1/20 | 0.85 |
| ▸ | CCR3 | P51677 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | EED | O75530 | 1/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.46 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL87612 | 0.92 | GBA1 (1.00) | GBA1CCR3POLBSLC6A4SLC18A3 | |
| Bromide SCHEMBL10728442 | 0.90 | GBA1 (0.96) | GBA1CCR3POLBSLC6A4SLC18A3 | |
| Hydrochloric Acid SCHEMBL4935892 | 0.90 | GBA1 (0.96) | GBA1CCR3POLBSLC6A4 | |
| SCHEMBL20806640 | 0.87 | GBA1 (0.63) | GBA1EEDSLC6A4 | |
| Formaldehyde SCHEMBL28466516 | 0.87 | GBA1 (0.89) | GBA1CCR3POLBSLC6A4 | |
| SCHEMBL8547993 | 0.85 | EED (0.61) | GBA1POLBEEDSLC6A4 | |
| SCHEMBL3473180 | 0.85 | EED (0.61) | GBA1POLBEEDSLC6A4 | |
| SCHEMBL1761058 | 0.85 | EED (0.61) | GBA1POLBEEDSLC6A4 | |
| SCHEMBL1428015 | 0.85 | GBA1 (0.85) | GBA1CCR3SLC6A4SLC18A3 | |
| SCHEMBL8101593 | 0.84 | GBA1 (0.82) | GBA1CCR3POLBSLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3672952-B1 | BENZIMIDAZOLE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS | MERCK PATENT GMBH (DE) | 2022-12-14 | — | — | EP | disclosed |
| WO-1997045422-A1 | ANTI-NEURODEGENERATIVELY EFFECTIVE 10-AMINOALIPHATYL-DIBENZ[b,f]OXEPINE SALTS | NOVARTIS AG (CH) | 1997-12-04 | — | — | WO | disclosed |